Email this article 
Hide
Show all
Editorial
Paediatric antiretroviral update
Southern African Journal of HIV Medicine | Vol 24, No 1 | a1506 |
DOI: https://doi.org/10.4102/sajhivmed.v24i1.1506
| © 2023 Gillian Sorour, Nosisa Sipambo, Moherndran Archary
| This work is licensed under CC Attribution 4.0
Submitted: 22 May 2023 | Published: 06 July 2023
Submitted: 22 May 2023 | Published: 06 July 2023
About the author(s)
Gillian Sorour, Department of Paediatrics and Child Health, University of the Witwatersrand, Johannesburg, South AfricaNosisa Sipambo, Department of Paediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa
Moherndran Archary, Discipline of Paediatrics and Child Health, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; and, Department of Paediatrics, King Edward VIII Hospital, Durban, South Africa
Abstract
No abstract available.
Keywords
paediatric; pediatric; ART; formulations; dolutegravir; dolutegravir-based; regimen; children; infants; HIV
Metrics
Total abstract views: 1788Total article views: 4340
Crossref Citations
1. Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis
Isaac Ravi Brenner, Clare F Flanagan, Martina Penazzato, Karen A Webb, Stephanie B Horsfall, Emily P Hyle, Elaine Abrams, Jason Bacha, Anne M Neilan, Intira Jeannie Collins, Sophie Desmonde, Siobhan Crichton, Mary-Ann Davies, Kenneth A Freedberg, Andrea L Ciaranello
The Lancet Global Health vol: 12 issue: 12 first page: e2068 year: 2024
doi: 10.1016/S2214-109X(24)00381-4